【24h】

22 Years of Photodynamic Therapy in China

机译:中国光动力疗法22年

获取原文
获取原文并翻译 | 示例

摘要

The development of laser medicine in China is correlated with the development of laser science in China. The first Chinese ruby laser was created in 1961. Chinese pharmacists produced the Chinese HpD in 1981 and the first case of PDT was treated using Chinese HpD and Chinese laser equipment in the same year in Beijing. Its success brought attention establishing a research group supported by the government in 1982. A systemic research on PDT was then carried out and obvious results were achieved. The step taken for PDT also accelerated the researches on other kinds of laser medicine and surgery. Since 1982, thousands of patients of malignant tumors including tumors of the lung, esophagus, cardia, stomach, rectum, bladder, other urinary genital organs, face and mouth, eyes, ENT, head and neck, breast, and skin were treated using PDT in China. HpD fluorescence was examined in some centers. Except the superficial tumor cases, PDT procedures were done through the endoscopes. Since 1990's, imaging guided percutaneous PDT was adopted in the organs cannot be reached by the endoscopes, such as liver cancer, peripheral lung cancer and others. PDT can be used for non-malignant cases such as occlusion of blood vessels, for example, we invented the treatment of port wine stains by PDT. Regular surgical operation combined with PDT for cerebral glioma showed to be a very good combination. HpD has been approved by the Chinese Government as a photosensitizer, so it is legal to be used in PDT. There are some second generation photosensitizers under studying in China, such as Hematoporphyrin monomethyl ether (HMME) etc. Lasers used for PDT now are mostly the diode laser of 630nm for the cancers. Research studies for PDT in China may be focalized on the aspects as new photosensitizers; the dosimetry in laser irradiation; atoptosis induced by PDT; preclinical and clinical studies for PDT new indications and new technologies.
机译:中国激光医学的发展与中国激光科学的发展相关。第一个中国红宝石激光器创建于1961年。中国药剂师于1981年生产了中国HPD,并于同年在北京使用中国HPD和中国激光设备治疗了第一例PDT。它的成功引起了人们的关注,并于1982年成立了由政府支持的研究小组。随后,对PDT进行了系统的研究,并取得了明显的成果。 PDT所采取的步骤也加快了对其他激光医学和外科手术的研究。自1982年以来,使用PDT治疗了成千上万的恶性肿瘤患者,包括肺,食道,card门癌,胃癌,直肠癌,膀胱癌,其他泌尿生殖器官,面部和口腔,眼睛,耳鼻喉,头颈,乳房和皮肤肿瘤在中国。在某些中心检查了HpD荧光。除浅表肿瘤病例外,PDT手术均通过内窥镜进行。自1990年代以来,内窥镜无法达到器官中影像引导的经皮PDT,例如肝癌,周围性肺癌等。 PDT可以用于非恶性情况,例如血管闭塞,例如,我们发明了PDT处理波特酒色斑的方法。定期手术治疗与PDT联合治疗脑胶质瘤是非常好的组合。 HpD已被中国政府批准用作光敏剂,因此在PDT中使用是合法的。在中国,有一些第二代光敏剂正在研究中,例如血卟啉单甲醚(HMME)等。用于PDT的激光器现在主要是用于癌症的630nm二极管激光器。中国对PDT的研究可能集中在新型光敏剂方面。激光辐照剂量; PDT诱导的细胞凋亡PDT新适应症和新技术的临床前和临床研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号